You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博暉創新(300318.SZ)子公司被列入廣東省新型冠狀病毒感染的肺炎疫情防控重點物資生產及配套企業
格隆匯 02-14 15:54

格隆匯2月14日丨博暉創新(300318.SZ)公佈,公司近日收到控股子公司廣東衞倫生物製藥有限公司(“廣東衞倫”)的通知,經廣東省新型冠狀病毒感染的肺炎疫情防控指揮部物資保障一組批覆(粵物資保障【2020】145號),廣東衞倫被列入廣東省新型冠狀病毒感染的肺炎疫情防控重點物資生產及配套企業復工復產名單。

廣東衞倫主要產品有凍幹靜注人免疫球蛋白、人血白蛋白等。靜注人免疫球蛋白是以人血漿為原料經過分離純化製備而成,具有免疫替代和免疫調節的雙重治療作用,可以提高人體的免疫力,對抗擊新冠狀病毒感染的肺炎疫情發揮重要作用。

廣東衞倫將全力做好防控重點物資的生產供應工作,支援疫情防控、切實履行公司的社會責任,為疫情防控提供幫助。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account